Author

M. Iwata

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:multiple species· 1

Frequent Co-Authors

A. Makino· 1 shared K. Tomonaga· 1 shared K. Yusa· 1 shared M. Sakai· 1 shared N. Aihara· 1 shared R. Komorizono· 1 shared T. Noda· 1 shared Y. Kamiya· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. Makino

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Genome-scale CRISPR-Cas9 screen identifies novel host factors as potential therapeutic targets for SARS-CoV-2 infection.

M. Sakai, Y. Masuda, Y. Tarumoto, N. Aihara, Y. Tsunoda, M. Iwata, Y. Kamiya, R. Komorizono, T. Noda, K. Yusa, K. Tomonaga, A. Makino

The paper identifies TRIM28, TRIM33, EHMT1, and EHMT2 as novel host factors involved in SARS-CoV-2 infection and shows that EHMT1/2 inhibition reduces viral growth and disease severity.

bioRxiv · Mar 6, 2023Microbiology